D. E. Shaw & Co., Inc. - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 86 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$4,963,142
-52.1%
278,203
-21.7%
0.01%
-54.5%
Q4 2022$10,353,034
+81.3%
355,530
+52.5%
0.01%
+83.3%
Q3 2022$5,710,000
+3681.5%
233,069
+538.7%
0.01%
Q2 2022$151,000
-86.5%
36,492
-62.4%
0.00%
-100.0%
Q1 2022$1,117,000
+66.0%
96,985
+206.4%
0.00%0.0%
Q1 2021$673,000
+128.1%
31,653
+188.2%
0.00%
Q4 2018$295,000
-80.6%
10,982
-78.9%
0.00%
-100.0%
Q3 2018$1,522,000
+29.5%
52,161
+38.8%
0.00%0.0%
Q2 2018$1,175,00037,5750.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,075,000$47,569,3755.56%
NEA Management Company, LLC 2,909,956$66,710,7415.15%
Opaleye Management Inc. 653,000$14,970,0254.87%
Frazier Life Sciences Management, L.P. 2,371,304$54,362,1443.61%
VR Adviser, LLC 1,090,000$24,988,2502.63%
RA Capital Management 5,676,067$130,123,8362.56%
Samsara BioCapital, LLC 345,293$7,915,8422.42%
SILVERARC CAPITAL MANAGEMENT, LLC 260,537$5,972,8111.81%
Logos Global Management LP 400,000$9,170,0001.22%
Cormorant Asset Management, LP 850,000$19,486,2501.14%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders